Concepedia

Joell J. Gills

JJ

Statistics

Publications

32

Citations

2.8K

H-Index

26

Active since

1997

Affiliations

National Cancer Institute(Current)

Center for Cancer Research

University of Illinois Chicago

Johns Hopkins University

National Institutes of Health

Joell J. Gills is an author at National Cancer Institute specializing in oncology, molecular oncology, and pharmacology.

Publications per year

1997–2022

32

Publications

32

Control of PD-L1 Expression by Oncogenic Activation of the AKT–mTOR Pathway in Non–Small Cell Lung Cancer

Kristin J. Lastwika, Willie Wilson, Qing Kay Li et al. · Cancer Research · 2015 · 776 citations

, , +17

Nelfinavir, A Lead HIV Protease Inhibitor, Is a Broad-Spectrum, Anticancer Agent that Induces Endoplasmic Reticulum Stress, Autophagy, and Apoptosis <i>In vitro</i> and <i>In vivo</i>

Joell J. Gills, Jaclyn LoPiccolo, Junji Tsurutani et al. · Clinical Cancer Research · 2007 · 326 citations

, , +17

Tobacco components stimulate Akt-dependent proliferation and NFκB-dependent survival in lung cancer cells

Junji Tsurutani, S. Sianna Castillo, John Brognard et al. · Carcinogenesis · 2005 · 289 citations · Full text

, , +17

Nelfinavir, a new anti-cancer drug with pleiotropic effects and many paths to autophagy

Joell J. Gills, Jaclyn LoPiccolo, Phillip A. Dennis · Autophagy · 2008 · 133 citations

, , +17

Inhibition of the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Pathway but not the MEK/ERK Pathway Attenuates Laminin-Mediated Small Cell Lung Cancer Cellular Survival and Resistance to Imatinib Mesylate or Chemotherapy

Junji Tsurutani, Kip A. West, Jacqueline Sayyah et al. · Cancer Research · 2005 · 124 citations

, , +17

1–5 of 32